Anavex Life Sciences
AVXL
AVXL
61 hedge funds and large institutions have $54.7M invested in Anavex Life Sciences in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% more capital invested
Capital invested by funds: $53.8M → $54.7M (+$947K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
85% less call options, than puts
Call options by funds: $982K | Put options by funds: $6.49M
Holders
61
Holding in Top 10
1
Calls
$982K
Puts
$6.49M
Top Buyers
| 1 | +$1.81M | |
| 2 | +$703K | |
| 3 | +$508K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$423K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$314K |
Top Sellers
| 1 | -$157K | |
| 2 | -$121K | |
| 3 | -$105K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$94K |
| 5 |
Barclays
London,
United Kingdom
|
-$68.2K |